|
ISIN No
|
INE695X01011
|
BSE Code / NSE Code
|
540729 / VANTABIO
|
Book Value (Rs.)
|
20.80
|
Face Value
|
10.00
|
|
Bookclosure
|
|
52Week High
|
75
|
EPS
|
0.00
|
P/E
|
0.00
|
|
Market Cap.
|
13.10 Cr.
|
52Week Low
|
20
|
P/BV / Div Yield (%)
|
1.00 / 0.00
|
Market Lot
|
750.00
|
|
Security Type
|
Other
|
|
The company history sections lists out major chronological events that happened to the company.
| The Company was originally incorporated as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation issued by the Registrar of Companies, Hyderabad dated April 29, 2016 with the name "Vanta Bioscience Private Limited`. The Company was converted into a public limited company pursuant to approval of the shareholders at an extraordinary general meeting held on February 13, 2017 and consequently, the name of the Company was changed to "Vanta Bioscience Limited" and a fresh certificate of incorporation consequent upon conversion to public limited company was issued by the Registrar of Companies, Hyderabad on March 17, 2017. The corporate identification number is U74999TG2016PLC109280.
The changes to the name of the Company were undertaken upon conversion of the Company from a private limited company to a public limited company.
Major Events and Milestones
2016
- Incorporation of the Company
2017
- The Company concluded the purchase of the preclinical CRO facility at Gummidipundi, Chennai from Kemin Industries South Asia Private Limited which was named as ?Vanta Bioscience? (a toxicology division of Kemin Industries South Asia Private Limited) along with leasehold rights in 4.8 acres of land situated at Plot K2B, SIPCOT Industrial Estate, Gummidipundi, Chennai - 601201.
|